levodopa has been researched along with inositol 3-phosphate in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rosin, AJ | 1 |
Kurisaki, H; Masuda, N; Nishiyama, K | 1 |
Cahill, LM; Charles, BG; Murdoch, BE; Theodoros, DG; Triggs, EJ; Yao, AA | 1 |
Benabid, AL; Gentil, M; Pollak, P; Tournier, CL | 1 |
Kleinow, J; Ramig, LO; Smith, A | 1 |
Amernik, K; Gołąb-Janowska, M; Honczarenko, K; Nowacki, P; Pawlukowska, W; Rotter, I; Safranow, K | 1 |
6 other study(ies) available for levodopa and inositol 3-phosphate
Article | Year |
---|---|
Clinical features, etiology and treatment of facial dyskinesias in the elderly.
Topics: Age Factors; Aged; Brain; Brain Damage, Chronic; Brain Stem; Chorea; Dementia; Dopamine; Face; Female; Haloperidol; Humans; Intracranial Arteriosclerosis; Levodopa; Lip; Male; Movement Disorders; Parasympathomimetics; Parkinson Disease; Phenothiazines; Tongue | 1974 |
[A case of rabbit syndrome--its unique pharmacological feature].
Topics: Antipsychotic Agents; Extrapyramidal Tracts; Female; Humans; Levodopa; Lip; Middle Aged; Movement Disorders; Syndrome | 1993 |
Effect of oral levodopa treatment on articulatory function in Parkinson's disease: preliminary results.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antiparkinson Agents; Dose-Response Relationship, Drug; Dysarthria; Female; Humans; Levodopa; Lip; Male; Middle Aged; Parkinson Disease | 1998 |
Effect of bilateral subthalamic nucleus stimulation and dopatherapy on oral control in Parkinson's disease.
Topics: Analysis of Variance; Antiparkinson Agents; Articulation Disorders; Dopamine Agents; Electric Stimulation Therapy; Electrodes, Implanted; Follow-Up Studies; Humans; Levodopa; Lip; Male; Middle Aged; Parkinson Disease; Pulse Therapy, Drug; Reaction Time; Subthalamic Nucleus; Tongue; Treatment Outcome | 1999 |
Speech motor stability in IPD: effects of rate and loudness manipulations.
Topics: Aged; Aging; Antiparkinson Agents; Dysarthria; Female; Humans; Levodopa; Lip; Loudness Perception; Male; Mandible; Middle Aged; Parkinson Disease; Severity of Illness Index; Speech | 2001 |
Articulation disorders and duration, severity and L-dopa dosage in idiopathic Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Articulation Disorders; Disease Progression; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Jaw; Levodopa; Lip; Male; Middle Aged; Parkinson Disease; Phonation; Phonetics; Range of Motion, Articular; Reflex, Abnormal; Respiration; Severity of Illness Index | 2015 |